speb/financial-data huggingface dataset:
Financial ratios for MTRN — annual report dated 2022-12-31
Total revenue: 1757109000
Gross profit: 343880000
Operating income: 120649000
Net income: 85990000
Capital expenditures: 76758000
Operating cash flow: 115958000
Depreciation & amortization: 53436000
Net tangible assets: 337291000
Owner earnings: 62668000
Return on net tangible assets (%): 18.57980201072664
Capex to operating income (%): 63.620916874570035
Buffett classification: The Good
Stock price: 86.09
P/E ratio: 20.825675586114667
Shares outstanding: 20801485
Book value: 799990000
P/B ratio: 2.238527786159827
Market cap (USD): 1790799843.65
Debt to equity: 0.6311478893486169
Current ratio: 2.8893389799300313
Quick ratio: 1.1188630923486382
Effective tax rate (%): 16.595538312318137
Interest coverage ratio: 5.507829262725405
COGS to revenue (%): 80.42921640034852
R&D to revenue (%): 1.6491293368823448
SG&A to revenue (%): 9.637307645683904
Free cash flow (dilution-adjusted): 29537000
Buyback yield (%): 0
Retained earnings: 769418000
Inventory turnover: 3.3403351611988277
Receivables turnover: 8.16458731198684
Capitalized R&D asset: 28977000
ROCI (R&D-adjusted, %): 9.44451791912507
FCF margin (%): 1.6809998696722857
Rule of 40 score: 1.6809998696722857
Financial ratios for MTRN — annual report dated 2023-12-31
Total revenue: 1665187000
Gross profit: 349042000
Operating income: 140486000
Net income: 95702000
Capital expenditures: 119222000
Operating cash flow: 144414000
Depreciation & amortization: 61644000
Net tangible assets: 430618000
Owner earnings: 38124000
Return on net tangible assets (%): 8.853322434268888
Capex to operating income (%): 84.8639722107541
Buffett classification: The Gruesome
Stock price: 128.63
P/E ratio: 27.9586112677896
Shares outstanding: 20801485
Book value: 885053000
P/B ratio: 3.0232031477775907
Market cap (USD): 2675695015.5499997
Debt to equity: 0.557858116971526
Current ratio: 2.7819447440145884
Quick ratio: 1.0501578462322791
Effective tax rate (%): 11.248156838015042
Interest coverage ratio: 4.485074865115092
COGS to revenue (%): 79.03887070941582
R&D to revenue (%): 1.6538683042805404
SG&A to revenue (%): 9.483079077605097
Free cash flow (dilution-adjusted): 14446000
Buyback yield (%): 0
Retained earnings: 854334000
Inventory turnover: 2.9804210626430887
Receivables turnover: 8.639236927163587
Capitalized R&D asset: 46954590
ROCI (R&D-adjusted, %): 9.595959527739625
Rosenberg metric: 0.17814128446699107
FCF margin (%): 0.8675301933056166
Revenue growth (%): -5.231434134137381
Rule of 40 score: -4.363903940831765
Financial ratios for MTRN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 110.94
Shares outstanding: 20801485
Market cap (USD): 2307716745.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTRN — annual report dated 2024-12-31
Total revenue: 1684739000
Gross profit: 325985000
Operating income: 133658000
Net income: 5888000
Capital expenditures: 79605000
Operating cash flow: 87817000
Depreciation & amortization: 68676000
Net tangible assets: 495850000
Owner earnings: -5041000
Return on net tangible assets (%): -1.0166380961984471
Capex to operating income (%): 59.55872450582831
Buffett classification: The Good
Stock price: 98.18
P/E ratio: 346.85628350883155
Shares outstanding: 20801485
Book value: 868881000
P/B ratio: 2.3504827442423073
Market cap (USD): 2042289797.3000002
Debt to equity: 0.5950619244752734
Current ratio: 3.1941570298234936
Quick ratio: 1.2478278511383383
Effective tax rate (%): 60.488525030197295
Interest coverage ratio: 3.844724427568749
COGS to revenue (%): 80.65071206875368
R&D to revenue (%): 1.7229968558928117
SG&A to revenue (%): 8.641575935500988
Free cash flow (dilution-adjusted): -3551000
Buyback yield (%): 0
Retained earnings: 849111000
Inventory turnover: 3.078987262604266
Receivables turnover: 8.693497701155357
Capitalized R&D asset: 57042210
ROCI (R&D-adjusted, %): 8.781168210763953
Rosenberg metric: -0.8372185911401597
FCF margin (%): -0.21077448791771308
Revenue growth (%): 1.1741624213977169
Rule of 40 score: 0.9633879334800037
Financial ratios for MTRN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 98.18
Shares outstanding: 20801485
Market cap (USD): 2042289797.3000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTRN — quarterly report dated 2025-03-31
Total revenue: 420330000
Gross profit: 76179000
Operating income: 31340000
Net income: 17698000
Capital expenditures: 20738000
Operating cash flow: 15502000
Depreciation & amortization: 16538000
Net tangible assets: 516742000
Owner earnings: 13498000
Return on net tangible assets (%): 2.6121352628584478
Capex to operating income (%): 66.17102744097001
Buffett classification: The Good
Stock price: 81.13
P/E ratio: 23.83919762190643
Shares outstanding: 20801485
Book value: 887929000
P/B ratio: 1.9006299806065574
Market cap (USD): 1687624478.05
Debt to equity: 0.6045021617719435
Current ratio: 2.8423003759567425
Quick ratio: 1.1955686532959873
Effective tax rate (%): 15.498472116119174
Interest coverage ratio: 4.530865982362296
COGS to revenue (%): 81.87638284205268
R&D to revenue (%): 1.5475935574429616
SG&A to revenue (%): 8.432660052815645
Free cash flow (dilution-adjusted): -8488000
Buyback yield (%): 0
Retained earnings: 864002000
Inventory turnover: 0.7825828912391447
Receivables turnover: 1.916514681743571
Capitalized R&D asset: 6505000
ROCI (R&D-adjusted, %): 2.391502045613494
FCF margin (%): -2.019365736445174
Rule of 40 score: -2.019365736445174
Financial ratios for MTRN — quarterly report dated 2025-06-30
Total revenue: 431658000
Gross profit: 82658000
Operating income: 38400000
Net income: 25140000
Capital expenditures: 14174000
Operating cash flow: 49940000
Depreciation & amortization: 17509000
Net tangible assets: 537323000
Owner earnings: 28475000
Return on net tangible assets (%): 5.299419529780039
Capex to operating income (%): 36.911458333333336
Buffett classification: The Good
Stock price: 79.05
P/E ratio: 38.38548459895419
Shares outstanding: 20801485
Book value: 910645000
P/B ratio: 1.8057062733007923
Market cap (USD): 1644357389.25
Debt to equity: 0.5615294653789347
Current ratio: 3.169943208524327
Quick ratio: 1.2525862329183575
Effective tax rate (%): 13.7741802716422
Interest coverage ratio: 4.665856622114216
COGS to revenue (%): 80.851044113627
R&D to revenue (%): 1.485666893698252
SG&A to revenue (%): 8.117305830078442
Free cash flow (dilution-adjusted): 33315000
Buyback yield (%): 0
Retained earnings: 886247000
Inventory turnover: 0.7849099377694614
Receivables turnover: 2.17594781653115
Capitalized R&D asset: 10771350
ROCI (R&D-adjusted, %): 2.664798603834206
Rosenberg metric: 0.9960030745580323
FCF margin (%): 7.717915572050095
Revenue growth (%): 2.6950253372350295
Rule of 40 score: 10.412940909285124
Financial ratios for MTRN — quarterly report dated 2025-09-30
Total revenue: 444808000
Gross profit: 86123000
Operating income: 38620000
Net income: 25412000
Capital expenditures: 22849000
Operating cash flow: 18282000
Depreciation & amortization: 17504000
Net tangible assets: 546046000
Owner earnings: 20067000
Return on net tangible assets (%): 3.6749651128293217
Capex to operating income (%): 59.163645779388915
Buffett classification: The Good
Stock price: 120.48
P/E ratio: 36.72033571868132
Shares outstanding: 20801485
Book value: 934579000
P/B ratio: 2.6815955770459214
Market cap (USD): 2506162912.8
Debt to equity: 0.5689631374126746
Current ratio: 3.294482354738504
Quick ratio: 1.3112831219975896
Effective tax rate (%): 9.5980078263963
Interest coverage ratio: 5.1193001060445384
COGS to revenue (%): 80.63816298268017
R&D to revenue (%): 1.4720958256146472
SG&A to revenue (%): 8.600564738044278
Free cash flow (dilution-adjusted): -8316000
Buyback yield (%): 0
Retained earnings: 908691000
Inventory turnover: 0.7675213821526162
Receivables turnover: 2.2776910117825375
Capitalized R&D asset: 12991360
ROCI (R&D-adjusted, %): 2.462835523719879
Rosenberg metric: 0.5403087478559176
FCF margin (%): -1.8695706911746193
Revenue growth (%): 3.046393209438954
Rule of 40 score: 1.1768225182643346
Financial ratios for MTRN — annual report dated 2025-12-31
Total revenue: 1786550000
Gross profit: 308626000
Operating income: 113252000
Net income: 74823000
Capital expenditures: 78635000
Operating cash flow: 103243000
Depreciation & amortization: 69074000
Net tangible assets: 556746000
Owner earnings: 65262000
Return on net tangible assets (%): 11.722042008384435
Capex to operating income (%): 69.43365238582983
Buffett classification: The Good
Stock price: 124.13
P/E ratio: 34.50928635646793
Shares outstanding: 20801485
Book value: 943277000
P/B ratio: 2.737359580536788
Market cap (USD): 2582088333.0499997
Debt to equity: 0.5647810770325153
Current ratio: 3.1134579210751507
Quick ratio: 1.2946017674686394
Effective tax rate (%): 8.238800112826675
Interest coverage ratio: 3.6899517789652028
COGS to revenue (%): 82.72502868657469
R&D to revenue (%): 1.4520164562984523
SG&A to revenue (%): 8.007444515966528
Free cash flow (dilution-adjusted): 12751000
Buyback yield (%): 0.30374638619491906
Retained earnings: 912361000
Inventory turnover: 3.2043032666928286
Receivables turnover: 8.014453875002243
Capitalized R&D asset: 54477960
ROCI (R&D-adjusted, %): 6.96453709342761
Rosenberg metric: -0.5980088190712416
FCF margin (%): 0.7137219781142425
Revenue growth (%): 6.043131903517399
Rule of 40 score: 6.756853881631642
Financial ratios for MTRN — quarterly report dated 2025-12-31
Total revenue: 489754000
Gross profit: 63666000
Operating income: 4892000
Net income: 6573000
Capital expenditures: 20874000
Operating cash flow: 19519000
Depreciation & amortization: 17523000
Net tangible assets: 556746000
Owner earnings: 3222000
Return on net tangible assets (%): 0.5787199189576575
Capex to operating income (%): 426.6966475878986
Buffett classification: The Gruesome
Stock price: 124.13
P/E ratio: 34.50928635646793
Shares outstanding: 20801485
Book value: 943277000
P/B ratio: 2.737359580536788
Market cap (USD): 2582088333.0499997
Debt to equity: 0.5647810770325153
Current ratio: 3.1134579210751507
Quick ratio: 1.2946017674686394
Effective tax rate (%): -97.32812969078356
Interest coverage ratio: 0.6114235720534933
COGS to revenue (%): 87.00041245196569
R&D to revenue (%): 1.3220923157340216
SG&A to revenue (%): 7.006987181319602
Free cash flow (dilution-adjusted): -3760000
Buyback yield (%): 0
Retained earnings: 912361000
Inventory turnover: 0.923806075480616
Receivables turnover: 2.1970338602881805
Capitalized R&D asset: 12978450
ROCI (R&D-adjusted, %): 0.3129141237859895
Rosenberg metric: -3.4295968234575445
FCF margin (%): -0.76773237176215
Revenue growth (%): 10.104584449919965
Rule of 40 score: 9.336852078157815
Financial ratios for NATHBIOGEN.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.692601872609785
Shares outstanding: 19004000
Market cap (USD): 51170205.98707636
Buyback yield (%): 0
Retained earnings: 49377673.743900836
Capitalized R&D asset: 1171726.2297243834
Rule of 40 score: 0
Financial ratios for NATHBIOGEN.NS — annual report dated 2023-03-31
Total revenue: 36706906.21193667
Gross profit: 22746820.950060904
Operating income: 5607332.521315469
Net income: 4264482.33861145
Capital expenditures: 296492.0828258222
Operating cash flow: 4673154.689403167
Depreciation & amortization: 733812.4238733252
Net tangible assets: 68545188.79415348
Owner earnings: 4701802.679658953
Return on net tangible assets (%): 6.8594204237715815
Capex to operating income (%): 5.287578036414821
Buffett classification: The Great
Stock price: 1.6677222898903776
P/E ratio: 7.431944109632862
Shares outstanding: 19004000
Book value: 69814056.02923265
P/B ratio: 0.4539686733543461
Market cap (USD): 31693394.397076737
Debt to equity: 0.18356085610392947
Current ratio: 2.4018063738717093
Quick ratio: 1.4414813596410168
Effective tax rate (%): 3.1879505479160386
Interest coverage ratio: 4.808812008398357
COGS to revenue (%): 38.031222738505
R&D to revenue (%): 3.109631319233206
SG&A to revenue (%): 9.652025111186251
Free cash flow (dilution-adjusted): 4362704.019488429
Buyback yield (%): 0
Retained earnings: 49410085.26187576
Inventory turnover: 0.5514273507480998
Receivables turnover: 3.0968334300996267
Capitalized R&D asset: 1926506.0258032787
ROCI (R&D-adjusted, %): 8.287533571914311
FCF margin (%): 11.885240325891935
Rule of 40 score: 11.885240325891935
Financial ratios for NATHBIOGEN.NS — annual report dated 2024-03-31
Total revenue: 39887864.25230843
Gross profit: 26268461.446216572
Operating income: 5616656.673462045
Net income: 4750989.327257465
Capital expenditures: 3204892.672982372
Operating cash flow: 8945173.282168126
Depreciation & amortization: 782156.1338289963
Net tangible assets: 72083811.00851421
Owner earnings: 2328252.7881040894
Return on net tangible assets (%): 3.2299246606552012
Capex to operating income (%): 57.06050519564535
Buffett classification: The Good
Stock price: 2.0458253358925145
P/E ratio: 8.18331972674508
Shares outstanding: 19004000
Book value: 73140508.45425111
P/B ratio: 0.531564047132921
Market cap (USD): 38878864.683301345
Debt to equity: 0.1809190306839256
Current ratio: 2.1782100767012005
Quick ratio: 1.3006648961504608
Effective tax rate (%): 4.682338619068585
Interest coverage ratio: 5.428083025252935
COGS to revenue (%): 34.14422672505877
R&D to revenue (%): 3.390125032732066
SG&A to revenue (%): 10.499123787786182
Free cash flow (dilution-adjusted): 5734272.694567694
Buyback yield (%): 0
Retained earnings: 52940940.16069073
Inventory turnover: 0.493129450811974
Receivables turnover: 3.526983753337447
Capitalized R&D asset: 2503689.2596136606
ROCI (R&D-adjusted, %): 7.503977505138011
Rosenberg metric: 3.0852356101541973
FCF margin (%): 14.375983277259161
Revenue growth (%): 8.665829863202552
Rule of 40 score: 23.041813140461713
Financial ratios for NATHBIOGEN.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 75520616.34018156
Buffett classification: The Gruesome
Stock price: 2.5370281892021023
Shares outstanding: 19004000
Book value: 76477830.86478738
P/B ratio: 0.6304269245402426
Market cap (USD): 48213683.70759675
Debt to equity: 0.19913383741045218
Current ratio: 2.843151018418602
Quick ratio: 1.9215200929449308
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NATHBIOGEN.NS — quarterly report dated 2025-03-31
Total revenue: 6075251.34440028
Gross profit: 4008557.4000467616
Operating income: -108487.25742342763
Net income: 173135.37526303483
Capital expenditures: 0
Depreciation & amortization: 156780.4535889642
Net tangible assets: 74492050.5026888
Owner earnings: 329915.828851999
Return on net tangible assets (%): 0.44288729686678535
Buffett classification: The Gruesome
Stock price: 1.682576730073521
P/E ratio: 46.17151193067611
Shares outstanding: 19004000
Book value: 75331681.08487257
P/B ratio: 0.4244653473522213
Market cap (USD): 31975688.178317193
Debt to equity: 0.19010402441265126
Current ratio: 1.8888756881999713
Quick ratio: 0.9635675585709095
Effective tax rate (%): 40.006377551020414
Interest coverage ratio: -0.6794055201698513
COGS to revenue (%): 34.018245948925966
SG&A to revenue (%): 21.614579825545484
Buyback yield (%): 0
Retained earnings: 55678442.833761975
Inventory turnover: 0.05230080960712488
Receivables turnover: 0.5845536914450262
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.14041318395065203
Rule of 40 score: 0
Financial ratios for NATHBIOGEN.NS — annual report dated 2025-03-31
Total revenue: 42659364.0402151
Gross profit: 26813233.5749357
Operating income: 5375520.224456394
Net income: 4512485.386953472
Capital expenditures: 913607.6689268178
Operating cash flow: 2055342.5298106147
Depreciation & amortization: 446118.7748421791
Net tangible assets: 74492050.5026888
Owner earnings: 4044996.4928688337
Return on net tangible assets (%): 5.430104911292285
Capex to operating income (%): 16.995707034461162
Buffett classification: The Great
Stock price: 1.682576730073521
P/E ratio: 7.086048028158832
Shares outstanding: 19004000
Book value: 75331681.08487257
P/B ratio: 0.4244653473522213
Market cap (USD): 31975688.178317193
Debt to equity: 0.19010402441265126
Current ratio: 1.8888756881999713
Quick ratio: 0.9635675585709095
Effective tax rate (%): 4.956273317983628
Interest coverage ratio: 4.386024151548102
COGS to revenue (%): 37.145725966147104
R&D to revenue (%): 3.4028284373987763
SG&A to revenue (%): 32.05510317389415
Free cash flow (dilution-adjusted): 1129413.1400514378
Buyback yield (%): 0
Retained earnings: 55678442.833761975
Inventory turnover: 0.40101024863334794
Receivables turnover: 4.104634904922864
Capitalized R&D asset: 2734309.765493522
ROCI (R&D-adjusted, %): 6.8902897570177215
Rosenberg metric: 0.40286392655358216
FCF margin (%): 2.6475151832707513
Revenue growth (%): 6.948228088562737
Rule of 40 score: 9.595743271833488
Financial ratios for NATHBIOGEN.NS — quarterly report dated 2025-06-30
Total revenue: 33196828.92581325
Gross profit: 16835501.98923473
Operating income: 4365656.4474608
Net income: 4362403.463608706
Capital expenditures: 0
Depreciation & amortization: 114088.46243856776
Owner earnings: 4476491.926047274
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.3978469459396208
P/E ratio: 2.6114436537548515
Shares outstanding: 19004000
Market cap (USD): 45568683.360636555
Effective tax rate (%): 1.8387620061654408
Interest coverage ratio: 11.673258033227995
COGS to revenue (%): 49.28581272971
SG&A to revenue (%): 30.560123172321756
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 446.4272512183656
Rule of 40 score: 446.4272512183656
Financial ratios for NATHBIOGEN.NS — quarterly report dated 2025-09-30
Total revenue: 4943585.11837655
Gross profit: 3015118.376550169
Operating income: 576843.2919954904
Net income: 310405.86245772266
Capital expenditures: 0
Depreciation & amortization: 111296.50507328071
Net tangible assets: 75920992.10822998
Owner earnings: 421702.3675310034
Return on net tangible assets (%): 0.555448968487979
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.8591882750845545
P/E ratio: 7.291047702218659
Shares outstanding: 19004000
Book value: 76646381.05975199
P/B ratio: 0.4609743277006483
Market cap (USD): 35332013.979706876
Debt to equity: 0.2277385095080792
Current ratio: 2.231079630767831
Quick ratio: 1.258398402091128
Effective tax rate (%): 11.746491260214738
Interest coverage ratio: 1.3990867080473601
COGS to revenue (%): 39.00947785156535
SG&A to revenue (%): 11.236362475370356
Buyback yield (%): 0
Inventory turnover: 0.05554377569088366
Receivables turnover: 0.24448795892787847
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7334980499927246
Revenue growth (%): -85.10826100461509
Rule of 40 score: -85.10826100461509
Financial ratios for NATHBIOGEN.NS — quarterly report dated 2025-12-31
Total revenue: 7347554.862426201
Gross profit: 4141951.6542274705
Operating income: 289484.23749582266
Net income: 178779.10214993873
Capital expenditures: 0
Depreciation & amortization: 108644.31324495934
Owner earnings: 287423.41539489804
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.732093126879804
P/E ratio: 6.550946692916815
Shares outstanding: 19004000
Market cap (USD): 32916697.783223797
Effective tax rate (%): 35.226217863341
Interest coverage ratio: 0.572085855806274
COGS to revenue (%): 43.62816294971118
SG&A to revenue (%): 18.400976364104974
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 48.628064177826936
Rule of 40 score: 48.628064177826936
Financial ratios for NMP — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -191047
Net income: 971953
Capital expenditures: 0
Operating cash flow: -591637
Net tangible assets: 116729713
Owner earnings: 971953
Return on net tangible assets (%): 0.8326526083380329
Buffett classification: The Gruesome
Stock price: 9.93
P/E ratio: 31.000823856709122
Shares outstanding: 12137500
Book value: 116729713
P/B ratio: 1.0325166737966707
Market cap (USD): 120525375
Debt to equity: 4.363070780444736e-05
Current ratio: 6.373520822271106
Quick ratio: 6.373520822271106
Free cash flow (dilution-adjusted): -591637
Buyback yield (%): 0
Retained earnings: 566266
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.16366612672130873
Rule of 40 score: 0
Financial ratios for NMP — annual report dated 2025-12-31
Total revenue: 0
Operating income: -504922
Net income: 1778677
Capital expenditures: 0
Operating cash flow: -542631
Net tangible assets: 117669892
Owner earnings: 1778677
Return on net tangible assets (%): 1.511582079126919
Buffett classification: The Gruesome
Stock price: 10.02
P/E ratio: 68.37539924337021
Shares outstanding: 12137500
Book value: 117669892
P/B ratio: 1.033550281494267
Market cap (USD): 121617750
Debt to equity: 4.217731414251659e-05
Current ratio: 4.01987226091919
Quick ratio: 4.01987226091919
Free cash flow (dilution-adjusted): -542631
Buyback yield (%): 0
Retained earnings: 785846
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.4291004193324151
Rule of 40 score: 0
Financial ratios for NMP — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -180419
Net income: 940180
Capital expenditures: 0
Operating cash flow: -91237
Net tangible assets: 117669892
Owner earnings: 940180
Return on net tangible assets (%): 0.7989979288839664
Buffett classification: The Gruesome
Stock price: 10.02
P/E ratio: 68.37539924337021
Shares outstanding: 12137500
Book value: 117669892
P/B ratio: 1.033550281494267
Market cap (USD): 121617750
Debt to equity: 4.217731414251659e-05
Current ratio: 4.01987226091919
Quick ratio: 4.01987226091919
Free cash flow (dilution-adjusted): -91237
Buyback yield (%): 0
Retained earnings: 785846
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.15332639210716706
Rule of 40 score: 0
Financial ratios for NTE.V — annual report dated 2021-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.968503937007874
Shares outstanding: 18974707
Market cap (USD): 18377078.433070865
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NTE.V — annual report dated 2022-11-30
Total revenue: 9142583.088235293
Gross profit: 7672980.147058823
Operating income: 662891.9117647058
Net income: 439249.26470588235
Capital expenditures: 607760.294117647
Operating cash flow: 3914738.2352941176
Depreciation & amortization: 5436273.529411764
Net tangible assets: 7487581.617647058
Owner earnings: 5267762.499999999
Return on net tangible assets (%): 70.35332326240969
Capex to operating income (%): 91.68316634000087
Buffett classification: The Gruesome
Stock price: 0.2205882352941176
P/E ratio: 9.528979257724158
Shares outstanding: 18974707
Book value: 7781699.2647058815
P/B ratio: 0.5378770098886801
Market cap (USD): 4185597.1323529407
Debt to equity: 0.41248116928944617
Current ratio: 0.6980853387865807
Quick ratio: 0.6980853387865807
Effective tax rate (%): 0.7649704975547523
Interest coverage ratio: 4.391103166446673
COGS to revenue (%): 16.074263990748527
SG&A to revenue (%): 17.214114333918857
Free cash flow (dilution-adjusted): -3116979.4117647056
Buyback yield (%): 0
Retained earnings: -2580202.205882353
Receivables turnover: 2.2507952690609785
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.8160189491857714
FCF margin (%): -34.09298424397855
Rule of 40 score: -34.09298424397855
Financial ratios for NTE.V — annual report dated 2023-11-30
Total revenue: 5240481.617647058
Gross profit: 3126196.3235294116
Operating income: -298155.1470588235
Net income: -235983.0882352941
Capital expenditures: 182492.64705882352
Operating cash flow: 3614908.8235294116
Depreciation & amortization: 2178744.117647059
Net tangible assets: 7656480.147058823
Owner earnings: 1760268.3823529412
Buffett classification: The Gruesome
Stock price: 0.14705882352941177
Shares outstanding: 18974707
Book value: 7766774.2647058815
P/B ratio: 0.3592737464915833
Market cap (USD): 2790398.088235294
Debt to equity: 0.33121953403889665
Current ratio: 0.8372077421351829
Quick ratio: 0.8372077421351829
Interest coverage ratio: -1.1223670152401723
COGS to revenue (%): 40.34524779168955
SG&A to revenue (%): 23.768948043757206
Free cash flow (dilution-adjusted): 3211358.088235294
Buyback yield (%): 0
Retained earnings: -2566691.9117647056
Receivables turnover: 1.5838146371165773
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.6900268599877184
FCF margin (%): 61.279827362073114
Revenue growth (%): -42.680514171202574
Rule of 40 score: 18.59931319087054
Financial ratios for NTE.V — annual report dated 2024-11-30
Total revenue: 8022611.428571429
Gross profit: 2402277.142857143
Operating income: -699827.142857143
Net income: -1364897.8571428573
Capital expenditures: 373862.85714285716
Operating cash flow: 1236637.8571428573
Depreciation & amortization: 2257451.4285714286
Net tangible assets: 6409780
Owner earnings: 518690.7142857142
Buffett classification: The Gruesome
Stock price: 0.0642857142857143
Shares outstanding: 18974707
Book value: 6409780.000000001
P/B ratio: 0.19030334783052505
Market cap (USD): 1219802.592857143
Debt to equity: 0.35389135263389915
Current ratio: 0.7012930546649145
Quick ratio: 0.7012930546649145
Interest coverage ratio: -2.8577703885194263
COGS to revenue (%): 70.05616981146859
SG&A to revenue (%): 10.528402935417537
Free cash flow (dilution-adjusted): 555888.5714285714
Buyback yield (%): 0
Retained earnings: -3855977.8571428573
Receivables turnover: 3.7821760840078285
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.386059313746536
FCF margin (%): 6.929022754970414
Revenue growth (%): 53.08920083901618
Rule of 40 score: 60.01822359398659
Financial ratios for NTE.V — quarterly report dated 2024-11-30
Total revenue: 2328407.8571428573
Gross profit: 1900653.5714285716
Operating income: 448661.4285714286
Net income: 156632.85714285716
Capital expenditures: 923.5714285714287
Operating cash flow: -487027.1428571429
Depreciation & amortization: 1194572.8571428573
Net tangible assets: 6409780
Owner earnings: 1350282.1428571432
Return on net tangible assets (%): 21.06596705124268
Capex to operating income (%): 0.20585041854659733
Buffett classification: The Great
Stock price: 0.0642857142857143
P/E ratio: 1.9469136538584315
Shares outstanding: 18974707
Book value: 6409780.000000001
P/B ratio: 0.19030334783052505
Market cap (USD): 1219802.592857143
Debt to equity: 0.35389135263389915
Current ratio: 0.7012930546649145
Quick ratio: 0.7012930546649145
Effective tax rate (%): 9.30349904872198
Interest coverage ratio: 5.3585681502145555
COGS to revenue (%): 18.371106436617787
SG&A to revenue (%): 11.269012455169396
Free cash flow (dilution-adjusted): -649962.142857143
Buyback yield (%): 0
Retained earnings: -3855977.8571428573
Receivables turnover: 1.0977034833992676
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.658535977768343
FCF margin (%): -27.914445523934045
Rule of 40 score: -27.914445523934045
Financial ratios for NTE.V — quarterly report dated 2025-02-28
Total revenue: 1037818.0555555556
Gross profit: 857353.4722222222
Operating income: 256634.72222222222
Net income: 203964.58333333334
Capital expenditures: 0
Operating cash flow: 1340949.3055555555
Depreciation & amortization: 471852.7777777778
Net tangible assets: 6442738.194444445
Owner earnings: 675817.3611111111
Return on net tangible assets (%): 10.489598377501457
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.0625
P/E ratio: 1.4535846960767291
Shares outstanding: 18974707
Book value: 6442738.194444444
P/B ratio: 0.18407067798015056
Market cap (USD): 1185919.1875
Debt to equity: 0.4728677625099663
Current ratio: 0.6701788134531368
Quick ratio: 0.6701788134531368
Effective tax rate (%): -19.65558823769056
Interest coverage ratio: 4.71809210106349
COGS to revenue (%): 17.38884598964976
SG&A to revenue (%): 12.417010046451624
Free cash flow (dilution-adjusted): 1333906.25
Buyback yield (%): 0
Retained earnings: -3544902.777777778
Receivables turnover: 0.5205498442660581
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.851337782168275
FCF margin (%): 128.52987504499959
Revenue growth (%): -55.42799547030213
Rule of 40 score: 73.10187957469745
Financial ratios for NTE.V — quarterly report dated 2025-05-31
Total revenue: 740996.3768115942
Gross profit: 235654.34782608697
Operating income: -428497.82608695654
Net income: -559571.7391304348
Capital expenditures: 62521.739130434784
Operating cash flow: 210552.1739130435
Depreciation & amortization: 445535.50724637683
Net tangible assets: 6170797.826086957
Owner earnings: -176557.97101449277
Return on net tangible assets (%): -2.861185473750194
Buffett classification: The Gruesome
Stock price: 0.09420289855072465
Shares outstanding: 18974707
Book value: 6170797.826086956
P/B ratio: 0.2896663363356699
Market cap (USD): 1787472.3985507248
Debt to equity: 0.32452701192773215
Current ratio: 0.6348199744641558
Quick ratio: 0.6348199744641558
Interest coverage ratio: -6.437123075918225
COGS to revenue (%): 68.197638315038
SG&A to revenue (%): 29.50306823460382
Free cash flow (dilution-adjusted): -899334.7826086957
Buyback yield (%): 0
Retained earnings: -4218613.043478261
Receivables turnover: 0.5774235753365328
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.741228338679443
FCF margin (%): -121.36831039288072
Revenue growth (%): -28.600550660594298
Rule of 40 score: -149.96886105347502
Financial ratios for NTE.V — quarterly report dated 2025-08-31
Total revenue: 2080181.02189781
Gross profit: 832935.7664233577
Operating income: 127640.14598540145
Net income: 99162.77372262772
Capital expenditures: 42624.087591240874
Operating cash flow: 1157062.0437956203
Depreciation & amortization: 465686.8613138686
Net tangible assets: 6319757.6642335765
Owner earnings: 522225.54744525545
Return on net tangible assets (%): 8.26337931279819
Capex to operating income (%): 33.39395083120314
Buffett classification: The Good
Stock price: 0.10218978102189781
P/E ratio: 4.888480526745822
Shares outstanding: 18974707
Book value: 6319757.664233576
P/B ratio: 0.30681890925319605
Market cap (USD): 1939021.1532846715
Debt to equity: 0.3696844376828642
Current ratio: 0.6963125341837665
Quick ratio: 0.6963125341837665
Effective tax rate (%): 1.3771324863883847
Interest coverage ratio: 2.261484144638146
COGS to revenue (%): 59.95849603206908
SG&A to revenue (%): 11.518649415688136
Free cash flow (dilution-adjusted): 2157126.2773722624
Buyback yield (%): 0
Retained earnings: -4150175.1824817513
Receivables turnover: 1.0424420929110523
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9674068880336477
FCF margin (%): 103.69896920818233
Revenue growth (%): 180.7275564353693
Rule of 40 score: 284.42652564355166
Financial ratios for OSG — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 2000000
Buffett classification: The Gruesome
Stock price: 16.05
Shares outstanding: 45013592
Market cap (USD): 722468151.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OSG — annual report dated 2022-12-31
Total revenue: 53612000
Net income: 522380000
Capital expenditures: 0
Operating cash flow: 70368000
Depreciation & amortization: 3793000
Net tangible assets: 865000000
Owner earnings: 526173000
Return on net tangible assets (%): 60.82924855491329
Buffett classification: The Gruesome
Stock price: 17.44
P/E ratio: 1.5028083856196641
Shares outstanding: 45013592
Book value: 1325000000
P/B ratio: 0.5924807882867925
Market cap (USD): 785037044.48
Debt to equity: 2.8271698113207546
COGS to revenue (%): 0
SG&A to revenue (%): 104.97276729090501
Free cash flow (dilution-adjusted): 59137000
Buyback yield (%): 1.8109973408219464
Retained earnings: 1245000000
Receivables turnover: 0.08185038167938931
Capitalized R&D asset: 0
FCF margin (%): 110.3055286129971
Rule of 40 score: 110.3055286129971
Financial ratios for OSG — annual report dated 2023-12-31
Total revenue: 124747000
Net income: 4951000
Capital expenditures: 0
Operating cash flow: 36948000
Depreciation & amortization: 5230000
Net tangible assets: 1230559000
Owner earnings: 10181000
Return on net tangible assets (%): 0.8273475713070239
Buffett classification: The Gruesome
Stock price: 16.48
P/E ratio: 149.83316424156737
Shares outstanding: 45013592
Book value: 1431693000
P/B ratio: 0.5181445995475287
Market cap (USD): 741823996.16
Debt to equity: 2.4271963332921236
COGS to revenue (%): 0
SG&A to revenue (%): 53.696682084539106
Free cash flow (dilution-adjusted): 24682000
Buyback yield (%): 0.6079609211006518
Retained earnings: 1246048000
Receivables turnover: 0.5662365132609198
Capitalized R&D asset: 0
FCF margin (%): 19.785646147803153
Revenue growth (%): 132.68484667611727
Rule of 40 score: 152.47049282392044
Financial ratios for OSG — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 1000000
Buffett classification: The Gruesome
Stock price: 11.21
Shares outstanding: 45013592
Market cap (USD): 504602366.32000005
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OSG — annual report dated 2024-12-31
Total revenue: 235319000
Net income: -556088000
Capital expenditures: 0
Operating cash flow: 762000
Depreciation & amortization: 19947000
Net tangible assets: 35355000
Owner earnings: -536141000
Return on net tangible assets (%): -1516.4502899165607
Buffett classification: The Gruesome
Stock price: 12.65
Shares outstanding: 45013592
Book value: 1195521000
P/B ratio: 0.4762960573674574
Market cap (USD): 569421938.8000001
Debt to equity: 0.1254683104688249
COGS to revenue (%): 0
SG&A to revenue (%): 54.88974540942295
Free cash flow (dilution-adjusted): -8594000
Buyback yield (%): 2.054364119628472
Retained earnings: 683643000
Receivables turnover: 0.5619021466606174
Capitalized R&D asset: 0
FCF margin (%): -3.652063794253758
Revenue growth (%): 88.63700129061219
Rule of 40 score: 84.98493749635843
Financial ratios for OSG — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 345000
Buffett classification: The Gruesome
Stock price: 12.65
Shares outstanding: 45013592
Market cap (USD): 569421938.8000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OSG — quarterly report dated 2025-03-31
Total revenue: 62756000
Net income: -44737000
Capital expenditures: 0
Operating cash flow: 31292000
Depreciation & amortization: 9176000
Net tangible assets: 77846000
Owner earnings: -35561000
Return on net tangible assets (%): -45.68121676129795
Buffett classification: The Gruesome
Stock price: 8.75
Shares outstanding: 45013592
Book value: 1211465000
P/B ratio: 0.32511787794117036
Market cap (USD): 393868930
Debt to equity: 0.12381703144539875
COGS to revenue (%): 0
SG&A to revenue (%): 61.39811332780929
Free cash flow (dilution-adjusted): 28943000
Buyback yield (%): 0.7926494735190206
Retained earnings: 681489000
Receivables turnover: 0.1303365372633398
Capitalized R&D asset: 0
FCF margin (%): 46.119892918605395
Rule of 40 score: 46.119892918605395
Financial ratios for OSG — quarterly report dated 2025-06-30
Total revenue: 54957000
Net income: -72699000
Capital expenditures: 0
Operating cash flow: -41755000
Depreciation & amortization: 9741000
Net tangible assets: 54127000
Owner earnings: -62958000
Return on net tangible assets (%): -116.31533245884678
Buffett classification: The Gruesome
Stock price: 7.1
Shares outstanding: 45013592
Book value: 1218708000
P/B ratio: 0.2622420655316942
Market cap (USD): 319596503.2
Debt to equity: 0.12308116464321232
COGS to revenue (%): 0
SG&A to revenue (%): 73.76676310570082
Free cash flow (dilution-adjusted): -56338000
Buyback yield (%): 0.05600812218148199
Retained earnings: 607548000
Receivables turnover: 0.10549603696402074
Capitalized R&D asset: 0
FCF margin (%): -102.51287370125735
Revenue growth (%): -12.427496972401045
Rule of 40 score: -114.94037067365839
Financial ratios for OSG — quarterly report dated 2025-09-30
Total revenue: 66605000
Net income: -111728000
Capital expenditures: 0
Operating cash flow: -41154000
Depreciation & amortization: 9746000
Net tangible assets: 58805000
Owner earnings: -101982000
Return on net tangible assets (%): -173.42402856899923
Buffett classification: The Gruesome
Stock price: 8.34
Shares outstanding: 45013592
Book value: 1147421000
P/B ratio: 0.3271801346497929
Market cap (USD): 375413357.28
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 80.63959162225058
Free cash flow (dilution-adjusted): -31146000
Buyback yield (%): 0
Retained earnings: 491733000
Receivables turnover: 0.11275567037186263
Capitalized R&D asset: 0
FCF margin (%): -46.76225508595451
Revenue growth (%): 21.19475226085849
Rule of 40 score: -25.567502825096017
Financial ratios for OSG — annual report dated 2025-12-31
Total revenue: 248644000
Net income: -259091000
Capital expenditures: 0
Operating cash flow: -52283000
Depreciation & amortization: 41952000
Net tangible assets: -299553000
Owner earnings: -217139000
Buffett classification: The Gruesome
Stock price: 7.78
Shares outstanding: 45013592
Book value: 1086166000
P/B ratio: 0.32242377846480186
Market cap (USD): 350205745.76
Debt to equity: 0.10823207502352311
COGS to revenue (%): 0
SG&A to revenue (%): 77.06761474236258
Free cash flow (dilution-adjusted): -61990000
Buyback yield (%): 8.549831167110431
Retained earnings: 370431000
Receivables turnover: 0.41598324315823637
Capitalized R&D asset: 0
FCF margin (%): -24.931226975113013
Revenue growth (%): 5.662526187855634
Rule of 40 score: -19.26870078725738
Financial ratios for OSG — quarterly report dated 2025-12-31
Total revenue: 64326000
Net income: -29673000
Capital expenditures: 0
Operating cash flow: -666000
Depreciation & amortization: 13289000
Net tangible assets: -299553000
Owner earnings: -16384000
Buffett classification: The Gruesome
Stock price: 7.78
Shares outstanding: 45013592
Book value: 1086166000
P/B ratio: 0.32242377846480186
Market cap (USD): 350205745.76
Debt to equity: 0.10823207502352311
COGS to revenue (%): 0
SG&A to revenue (%): 91.4762304511395
Free cash flow (dilution-adjusted): -3449000
Buyback yield (%): 7.6072424060847315
Retained earnings: 370431000
Receivables turnover: 0.10761787173387137
Capitalized R&D asset: 0
FCF margin (%): -5.361751080434039
Revenue growth (%): -3.42166504016215
Rule of 40 score: -8.78341612059619
Financial ratios for PACEDIGITK.NS — quarterly report dated 2025-12-31
Total revenue: 71735100.81318927
Gross profit: 18843154.728751253
Operating income: 12625153.169210205
Net income: 8775648.88047232
Capital expenditures: 0
Depreciation & amortization: 512197.8389216888
Owner earnings: 9287846.719394008
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.0996992313690543
P/E ratio: 14.450235550726017
Shares outstanding: 215851327
Market cap (USD): 453222865.3918904
Effective tax rate (%): 31.04682713347921
Interest coverage ratio: 12.228744065602072
COGS to revenue (%): 73.7323088486038
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 19.27924180010514
Rule of 40 score: 19.27924180010514
Financial ratios for PIA.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7819548872180451
Shares outstanding: 257975845
Market cap (USD): 201725472.78195488
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PIA.AX — annual report dated 2022-06-30
Total revenue: -79877000
Net income: -61651000
Capital expenditures: 0
Net tangible assets: 287531000
Owner earnings: -61651000
Return on net tangible assets (%): -21.4415141323892
Buffett classification: The Gruesome
Stock price: 0.496551724137931
Shares outstanding: 257975845
Book value: 287531000
P/B ratio: 0.4455114426642333
Market cap (USD): 128098350.62068966
Debt to equity: 0
Free cash flow (dilution-adjusted): 16930000
Buyback yield (%): 0
Retained earnings: -194699000
Receivables turnover: -186.6285046728972
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PIA.AX — annual report dated 2023-06-30
Total revenue: 55366000
Net income: 38356000
Capital expenditures: 0
Net tangible assets: 312850000
Owner earnings: 38356000
Return on net tangible assets (%): 12.260188588780565
Buffett classification: The Gruesome
Stock price: 0.5894039735099338
P/E ratio: 3.964229536776066
Shares outstanding: 257975845
Book value: 312850000
P/B ratio: 0.48602201730088795
Market cap (USD): 152051988.11258277
Debt to equity: 0
Effective tax rate (%): 25.176544028715224
COGS to revenue (%): 0
SG&A to revenue (%): 0.2799552071668533
Free cash flow (dilution-adjusted): 11909000
Buyback yield (%): 0.25254520165542166
Retained earnings: -194699000
Receivables turnover: 65.6773428232503
Capitalized R&D asset: 0
FCF margin (%): 21.50959072354875
Rule of 40 score: 21.50959072354875
Financial ratios for PIA.AX — annual report dated 2024-06-30
Total revenue: 52782000
Net income: 33625000
Capital expenditures: 0
Net tangible assets: 332935000
Owner earnings: 33625000
Return on net tangible assets (%): 10.099568984937
Buffett classification: The Gruesome
Stock price: 0.6866666666666666
P/E ratio: 5.268205607930607
Shares outstanding: 257975845
Book value: 333080000
P/B ratio: 0.5318344348705015
Market cap (USD): 177143413.56666666
Debt to equity: 0
Effective tax rate (%): 30.27041599270043
COGS to revenue (%): 0
SG&A to revenue (%): 0.30502822932060175
Free cash flow (dilution-adjusted): 17878000
Buyback yield (%): 0.45443405644717577
Retained earnings: -194699000
Receivables turnover: 124.48584905660377
Capitalized R&D asset: 0
FCF margin (%): 33.87139555151377
Revenue growth (%): -4.667124227865477
Rule of 40 score: 29.204271323648292
Financial ratios for PLTR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.21
Shares outstanding: 2296071334
Market cap (USD): 41811458992.14
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PLTR — annual report dated 2022-12-31
Total revenue: 1905871000
Gross profit: 1497322000
Operating income: -161201000
Net income: -371094000
Capital expenditures: 40027000
Operating cash flow: 223737000
Depreciation & amortization: 22522000
Net tangible assets: 2565326000
Owner earnings: -388599000
Return on net tangible assets (%): -15.148133219715545
Buffett classification: The Gruesome
Stock price: 6.42
Shares outstanding: 2296071334
Book value: 2642437000
P/B ratio: 5.578478489470137
Market cap (USD): 14740777964.28
Debt to equity: 0.09438408559977021
Current ratio: 5.173269086523988
Quick ratio: 5.173269086523988
Interest coverage ratio: -39.724248398225726
COGS to revenue (%): 21.43634065474526
R&D to revenue (%): 18.87215871378493
SG&A to revenue (%): 68.14962817525425
Free cash flow (dilution-adjusted): -381088000
Buyback yield (%): 0
Retained earnings: -5859438000
Receivables turnover: 7.377203440347441
Capitalized R&D asset: 359679000
ROCI (R&D-adjusted, %): 2.4307317992054998
FCF margin (%): -19.99547713355206
Rule of 40 score: -19.99547713355206
Financial ratios for PLTR — annual report dated 2023-12-31
Total revenue: 2225012000
Gross profit: 1793907000
Operating income: 119966000
Net income: 217375000
Capital expenditures: 15114000
Operating cash flow: 712183000
Depreciation & amortization: 33354000
Net tangible assets: 3475561000
Owner earnings: 235615000
Return on net tangible assets (%): 6.779193344614007
Capex to operating income (%): 12.598569594718503
Buffett classification: The Great
Stock price: 17.17
P/E ratio: 181.3619082451064
Shares outstanding: 2296071334
Book value: 3560965000
P/B ratio: 11.071028444475024
Market cap (USD): 39423544804.78001
Debt to equity: 0.06441849330167525
Current ratio: 5.547611451734409
Quick ratio: 5.547611451734409
Effective tax rate (%): 8.315794357440815
Interest coverage ratio: 34.572334293948124
COGS to revenue (%): 19.375401121432155
R&D to revenue (%): 18.185250236852653
SG&A to revenue (%): 57.04764738347479
Free cash flow (dilution-adjusted): 221166000
Buyback yield (%): 0
Retained earnings: -5649613000
Receivables turnover: 6.099532874248871
Capitalized R&D asset: 645608930
ROCI (R&D-adjusted, %): 6.101794692841221
Rosenberg metric: 0.8245824749290339
FCF margin (%): 9.939991334878194
Revenue growth (%): 16.745152216493143
Rule of 40 score: 26.685143551371336
Financial ratios for PLTR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 37.2
Shares outstanding: 2296071334
Market cap (USD): 85413853624.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PLTR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 75.63
Shares outstanding: 2296071334
Market cap (USD): 173651874990.41998
Buyback yield (%): 0.010709933308250206
Capitalized R&D asset: 171502000
Rule of 40 score: 0
Financial ratios for PLTR — annual report dated 2024-12-31
Total revenue: 2865507000
Gross profit: 2299517000
Operating income: 310403000
Net income: 467918000
Capital expenditures: 12634000
Operating cash flow: 1153865000
Depreciation & amortization: 31587000
Net tangible assets: 5003275000
Owner earnings: 486871000
Return on net tangible assets (%): 9.73104616476208
Capex to operating income (%): 4.070192620561013
Buffett classification: The Great
Stock price: 75.63
P/E ratio: 371.11603954201377
Shares outstanding: 2296071334
Book value: 5094407000
P/B ratio: 34.08676907644403
Market cap (USD): 173651874990.41998
Debt to equity: 0.04695718265148426
Current ratio: 5.958013810995384
Quick ratio: 5.958013810995384
Effective tax rate (%): 4.34508854740552
COGS to revenue (%): 19.751827512548388
R&D to revenue (%): 17.72384433191055
SG&A to revenue (%): 51.69193444650458
Free cash flow (dilution-adjusted): 449593000
Buyback yield (%): 0.03696821586495485
Retained earnings: -5187423000
Receivables turnover: 4.983074456393205
Capitalized R&D asset: 897670150
ROCI (R&D-adjusted, %): 6.31507222696126
Rosenberg metric: 1.249579856854759
FCF margin (%): 15.689823825242794
Revenue growth (%): 28.78613688375613
Rule of 40 score: 44.475960708998926
Financial ratios for PLTR — quarterly report dated 2025-03-31
Total revenue: 883855000
Gross profit: 710885000
Operating income: 176048000
Net income: 217717000
Capital expenditures: 6184000
Operating cash flow: 310263000
Depreciation & amortization: 6622000
Net tangible assets: 5424155000
Owner earnings: 218155000
Return on net tangible assets (%): 4.021916777820693
Capex to operating income (%): 3.512678360447151
Buffett classification: The Great
Stock price: 84.4
P/E ratio: 222.5232992710721
Shares outstanding: 2296071334
Book value: 5518973000
P/B ratio: 35.11313075632007
Market cap (USD): 193788420589.6
Debt to equity: 0.04431911516870983
Current ratio: 6.4940249709802025
Quick ratio: 6.4940249709802025
Effective tax rate (%): 2.50720951476831
COGS to revenue (%): 19.569952084900805
R&D to revenue (%): 15.261439942071947
SG&A to revenue (%): 45.25040872088748
Free cash flow (dilution-adjusted): 148740000
Buyback yield (%): 0.009287448623215568
Retained earnings: -4973392000
Receivables turnover: 1.2187657283113051
Capitalized R&D asset: 249795340
ROCI (R&D-adjusted, %): 3.4689703163651204
FCF margin (%): 16.828552194647312
Rule of 40 score: 16.828552194647312
Financial ratios for PLTR — quarterly report dated 2025-06-30
Total revenue: 1003697000
Gross profit: 810763000
Operating income: 269317000
Net income: 328572000
Capital expenditures: 7634000
Operating cash flow: 539251000
Depreciation & amortization: 6530000
Net tangible assets: 5928901000
Owner earnings: 327468000
Return on net tangible assets (%): 5.5232495870651235
Capex to operating income (%): 2.8345778394976926
Buffett classification: The Great
Stock price: 136.32
P/E ratio: 572.9576181304767
Shares outstanding: 2296071334
Book value: 6025564000
P/B ratio: 51.94541859498629
Market cap (USD): 313000444250.88
Debt to equity: 0.03946717684850746
Current ratio: 6.323549979809846
Quick ratio: 6.323549979809846
Effective tax rate (%): 1.0825847161677222
COGS to revenue (%): 19.222335027403687
R&D to revenue (%): 13.45455849723572
SG&A to revenue (%): 40.49060622877223
Free cash flow (dilution-adjusted): 371646000
Buyback yield (%): 0.005941205624965408
Retained earnings: -4646665000
Receivables turnover: 1.342767203043811
Capitalized R&D asset: 282014290
ROCI (R&D-adjusted, %): 3.9221239744176533
Rosenberg metric: 0.7404458480676704
FCF margin (%): 37.02770856144832
Revenue growth (%): 13.559011376300411
Rule of 40 score: 50.58671993774873